|
东瑞制药(控股)有限公司, 02348.HK - 综合现金流量表 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
2011-12 |
2010-12 |
2009-12 |
2008-12 |
2007-12 |
2006-12 |
2005-12 |
经营活动之现金流量 |
352,706 |
345,088 |
444,865 |
393,826 |
361,702 |
424,996 |
261,458 |
226,896 |
117,130 |
282,888 |
163,790 |
110,231 |
140,214 |
53,507 |
39,269 |
投资回报及融资费用之现金流量 |
-83,937 |
-170,188 |
-77,932 |
-84,090 |
-54,839 |
-49,369 |
-43,945 |
-54,317 |
-64,465 |
-46,644 |
-39,729 |
-40,143 |
-24,731 |
-41,715 |
-31,290 |
已收利息 |
23,704 |
33,747 |
13,126 |
17,088 |
21,248 |
12,582 |
7,562 |
3,260 |
2,563 |
2,308 |
477 |
936 |
945 |
858 |
1,258 |
已付利息 |
-5,247 |
-1,152 |
-13 |
-157 |
-1,524 |
-2,804 |
-3,600 |
-3,825 |
-2,152 |
-549 |
-395 |
-343 |
0 |
-976 |
-202 |
已收股息 |
485 |
258 |
346 |
367 |
159 |
267 |
220 |
216 |
189 |
174 |
135 |
162 |
68 |
2 |
7 |
已付股息 |
-102,879 |
-203,041 |
-91,391 |
-101,388 |
-74,722 |
-59,414 |
-48,127 |
-53,968 |
-65,065 |
-48,577 |
-39,946 |
-40,898 |
-25,744 |
-41,599 |
-32,353 |
其他 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
退回/(已缴)税项 |
-76,869 |
-70,794 |
-54,124 |
-73,568 |
-63,380 |
-47,198 |
-30,196 |
-23,272 |
-34,144 |
-30,544 |
-24,803 |
-12,432 |
-9,663 |
-2,894 |
-4,780 |
投资活动之现金流量 |
-623,048 |
-46,741 |
-465,868 |
-123,194 |
-167,607 |
-59,517 |
-90,848 |
-112,805 |
-152,010 |
-81,839 |
-61,008 |
-83,951 |
-62,679 |
-16,129 |
-66,732 |
增添固定资产 |
-57,171 |
-16,863 |
-15,697 |
-25,433 |
-42,812 |
-59,952 |
-88,681 |
-107,643 |
-148,070 |
-83,660 |
-61,858 |
-83,551 |
-36,196 |
-14,266 |
-65,283 |
出售固定资产 |
1,704 |
154 |
169 |
455 |
53 |
156 |
730 |
491 |
184 |
2,757 |
2,503 |
320 |
123 |
176 |
910 |
投资增加 |
-979,866 |
-627,150 |
-500,020 |
-4,060 |
-2,797 |
-566 |
-953 |
-140 |
-628 |
-1,119 |
-2,338 |
-4,688 |
-16,276 |
-4,189 |
-1,266 |
投资减少 |
545,684 |
549,892 |
211,520 |
452 |
4,128 |
1,384 |
822 |
127 |
627 |
802 |
2,295 |
3,968 |
15,742 |
2,150 |
815 |
与关联人士之现金流量 |
750 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-627 |
0 |
0 |
0 |
0 |
0 |
其他 |
-134,149 |
47,226 |
-161,840 |
-94,608 |
-126,179 |
-539 |
-2,766 |
-5,640 |
-4,123 |
8 |
-1,610 |
0 |
-26,072 |
0 |
-1,908 |
融资活动前之现金流量 |
-431,148 |
57,365 |
-153,059 |
112,974 |
75,876 |
268,912 |
96,469 |
36,502 |
-133,489 |
123,861 |
38,250 |
-26,295 |
43,141 |
-7,231 |
-63,533 |
融资活动之现金流量 |
174,213 |
0 |
-46,458 |
-15,726 |
38,262 |
-34,546 |
-43,403 |
22,989 |
26,103 |
2,747 |
9,354 |
-9,158 |
-4,901 |
-631 |
17,626 |
新增贷款 |
216,776 |
102,762 |
0 |
17,992 |
25,127 |
55,436 |
133,230 |
235,579 |
131,465 |
48,808 |
5,283 |
0 |
0 |
0 |
17,626 |
偿还贷款 |
-31 |
-102,762 |
-8,437 |
-18,391 |
-212,993 |
-121,497 |
-80,747 |
-142,017 |
-67,686 |
-1,735 |
0 |
0 |
0 |
0 |
0 |
定息/债项工具融资 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
偿还定息/债项工具 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
股本融资 |
0 |
0 |
3,511 |
1,633 |
6,350 |
10,039 |
1,001 |
933 |
918 |
6,001 |
4,189 |
1,024 |
2,939 |
-631 |
0 |
与关联人士之现金流量 |
750 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
-627 |
0 |
0 |
0 |
0 |
0 |
其他 |
-43,282 |
0 |
-41,532 |
-16,960 |
219,778 |
21,476 |
-96,887 |
-71,506 |
-38,594 |
-49,700 |
-118 |
-10,182 |
-7,840 |
0 |
0 |
现金及等同现金之增加/(减少) |
-256,935 |
57,365 |
-199,517 |
97,248 |
114,138 |
234,366 |
53,066 |
59,491 |
-107,386 |
126,608 |
47,604 |
-35,453 |
38,240 |
-7,862 |
-45,907 |
年初之现金及现金等同项目 |
525,363 |
460,747 |
663,296 |
563,280 |
443,366 |
205,771 |
155,694 |
97,805 |
210,975 |
86,450 |
38,936 |
76,843 |
44,023 |
51,948 |
98,382 |
外汇兑换率变动之影响/(其他) |
-9,807 |
7,251 |
-3,032 |
2,768 |
5,776 |
3,229 |
-2,989 |
-1,602 |
-5,784 |
-2,083 |
-90 |
-2,454 |
-5,420 |
-63 |
-527 |
年终之现金及现金等同项目 |
258,621 |
525,363 |
460,747 |
663,296 |
563,280 |
443,366 |
205,771 |
155,694 |
97,805 |
210,975 |
86,450 |
38,936 |
76,843 |
44,023 |
51,948 |
货币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
人民币 |
单位 |
千 |
千 |
千 |
千 |
千 |
千 |
千 |
核数师意见 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
说明:1代表无保留意见;2代表保留意见;3代表修改意见
|
|